Compositions and methods for detecting human immunodeficiency virus 2 (HIV-2)
First Claim
Patent Images
1. A composition for detecting an HIV-2 nucleic acid sequence, comprising:
- a first amplification oligonucleotide comprising a sequence of 9-34 contiguous bases contained within the sequence of SEQ ID NO;
9, said first amplification oligonucleotide having a length of up to 100 nucleotides; and
a second amplification oligonucleotide comprising a sequence of 19-40 contiguous bases from the sequence of SEQ ID NO;
1, said second amplification oligonucleotide having a length of up to 100 nucleotides.
6 Assignments
0 Petitions
Accused Products
Abstract
Compositions and methods for synthesizing and detecting HIV-2 specific amplicons. Particularly described are oligonucleotides that are useful as hybridization probes, and amplification primers that facilitate detection of very low levels of HIV-2 nucleic acids.
-
Citations
56 Claims
-
1. A composition for detecting an HIV-2 nucleic acid sequence, comprising:
-
a first amplification oligonucleotide comprising a sequence of 9-34 contiguous bases contained within the sequence of SEQ ID NO;
9, said first amplification oligonucleotide having a length of up to 100 nucleotides; and
a second amplification oligonucleotide comprising a sequence of 19-40 contiguous bases from the sequence of SEQ ID NO;
1, said second amplification oligonucleotide having a length of up to 100 nucleotides. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26, 27, 28, 29, 30)
-
-
25. A method for determining whether a biological sample comprising nucleic acids includes an HIV-2 nucleotide base sequence, said method comprising the steps of:
-
contacting the nucleic acids of the biological sample with a composition comprising, a first amplification oligonucleotide comprising a sequence of 9-34 contiguous bases contained within the sequence of SEQ ID NO;
9, said first amplification oligonucleotide having a length of up to 100 nucleotides, anda second amplification oligonucleotide comprising a sequence of 19-40 contiguous bases from the sequence of SEQ ID NO;
1, said second amplification oligonucleotide having a length of up to 100 nucleotides;
amplifying any of said HIV-2 nucleotide base sequence present in said biological sample to produce amplified nucleic acids; and
detecting said amplified nucleic acids produced in the amplifying step, whereby detection of said amplified nucleic acids indicates that said biological sample included the HIV-2 nucleotide base sequence.
-
-
31. An oligonucleotide comprising the sequence of SEQ ID NO:
- 21 or the complement thereof and a detectable label, said oligonucleotide having a length of up to 35 nucleotides.
- View Dependent Claims (32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)
-
43. A method for detecting the presence of HIV-2 nucleic acids in a biological sample, comprising the steps of:
-
(a) providing to said biological sample a hybridization probe comprising the sequence of SEQ ID NO;
21 or the complement thereof and a detectable label, said oligonucleotide having a length of up to 35 nucleotides;
(b) hybridizing under a high stringency condition any HIV-2 nucleic acid that may be present in the biological sample with said hybridization probe to form a probe;
target duplex; and
(c) detecting said probe;
target duplex as an indicator of the presence of HIV-2 in the biological sample. - View Dependent Claims (44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)
-
-
55. A kit for detecting HIV-2 nucleic acids, comprising:
-
(a) a first amplification oligonucleotide comprising a sequence of 9-34 contiguous bases contained within the sequence of SEQ ID NO;
9, said first amplification oligonucleotide having a length of up to 100 nucleotides; and
(b) a second amplification oligonucleotide comprising a sequence of 19-40 contiguous bases from the sequence of SEQ ID NO;
1, said second amplification oligonucleotide having a length of up to 100 nucleotides. - View Dependent Claims (56)
-
Specification